Epidermal growth factor receptor (EGFR) belongs to the HER/erbB family of receptor tyrosine kinases (RTKs), and is a prominent therapeutic target for non-small cell lung carcinomas (NSCLCs). This evidence concerns the gene EGFR and non-small cell lung carcinoma.